They carry quiet signals from deep within the body. One such silent communicator is the kidney. Though it sits far from the ...

Results from the Phase II WILLOW trial show that enpatoran achieved a statistically significant dose-response and clinically ...

Cohort analyses from the WILLOW study reveal clear proof of concept in patients with CLE and SLE with active lupus rash, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

WILLOW is a global, multicenter, randomized, placebo-controlled Phase 2 study evaluating three doses of enpatoran taken twice daily (25 mg, 50 mg and 100 mg) versus placebo plus standard of care (SoC) ...

Recent findings regarding interferon and Janus kinase inhibition may hold clues to improving outcomes in patients with ...

BENGALURU: No rainbow yet. Intermittent rains continued to lash the city on Tuesday, not giving citizens any respite from pre ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, presented 11 ...

When was the last time you cleaned out your makeup bag or bathroom shelf? If you’re holding on to that mascara from 2021 or a half-used serum that’s been %% ...

Discover commonly overlooked causes of allergic reactions and rashes, from hidden household allergens to unexpected food ...

The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...